Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Family Medicine and Primary Care|November 10, 2022
Efficacy of phenytoin for 7 days versus 21 days as prophylactic anticonvulsant in traumatic brain injury patients - A comparative studySantosh Kumar, Alok Kumar Bharti, Ravi Shankar Prasad, et al.Microbiology Spectrum|August 8, 2025
Emergence of drug-resistant <i>Klebsiella pneumoniae</i> phylogroups (<i>K. quasipneumoniae</i> and <i>K. variicola</i>) causing human infectionsKajal Mishra, Tuhina Banerjee, Ghanshyam Yadav, et al.Indian Journal of Anaesthesia|December 15, 2021
Quantitative correlation of colony forming units of <i>Acinetobacter baumannii</i> obtained from endotracheal tube aspirate culture with clinical pulmonary infection scoreRakesh C Chaurasia, Bikram K Gupta, Ghanshyam Yadav, et al.JSLS : Journal of the Society of Laparoendoscopic Surgeons|May 18, 2019
A Novel Approach to Combined Vaginal and Laparoscopic Gynecological SurgeryChristina Tierney, Sophie H Chung, Jacqueline Feinberg, et al.World Journal of Surgical Oncology|September 20, 2022
Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378)Kishan Soni, J F Neville, Roli Purwar, et al.Microbial Drug Resistance (Larchmont, N.Y.)|December 19, 2022
Reservoir of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in the Hospital Environment and Colonization Pressure: A Surveillance-Based Study in Indian Intensive Care UnitSwati Sharma, Arghya Das, Rahul Garg, et al.Journal of Neurosurgical Anesthesiology|June 15, 2013
Evaluating the role of flupirtine for postcraniotomy pain and compare it with diclofenac sodium: a prospective, randomized, double blind, placebo-controlled studyGhanshyam Yadav, Sujali Choupoo, Saurabh K Das, et al.Journal of Medical Internet Research|January 10, 2022
Applying Human-Centered Design Principles to Digital Syndromic Surveillance at a Mass Gathering in India: ViewpointAhmed Shaikh, Abhishek Bhatia, Ghanshyam Yadav, et al.Gynecologic Oncology|May 31, 2022
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neuGhanshyam Yadav, Dana M Roque, Stefania Bellone, et al.Gynecologic Oncology|January 12, 2019
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancersElena Bonazzoli, Emiliano Cocco, Salvatore Lopez, et al.Pageof 5